“It’s early in the trend, but there is a massive shift taking place toward more ambulatory hip and knee replacement surgeries that allow that patients go home on the same day of their operations,” says Michael P. Ast, MD, a hip and knee replacement surgeon at Hospital for Special Surgery. “Currently, about 5% of total hip and knee replacement surgeries are performed on an ambulatory basis, but that figure is expected to rise to about 50% in the next five years.”
Factors driving the trend to ambulatory total joint replacements include improvements in surgical techniques, implant devices and pain control, as well as the potential for significantly reduced healthcare system costs. “But before the trend is adopted on a more widespread basis, we need to ensure that the risks of complications for patients do not increase,” says Dr. Ast.
Dr. Ast and colleagues, including Alvin C. Ong, MD at the Rothman Orthopedic Institute, recently conducted a study to compare patient outcomes and costs for in-patient hip and knee replacement surgeries to those performed in an ambulatory surgery center. They found no increased risk of 90-day complication rates or readmission rates for patients who were discharged the same day compared to patients who had the same procedures and stayed in the hospital. An abstract of the study was presented as a poster and included in the program book at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting.
Dr. Ast performed the ambulatory surgeries at a community based ambulatory surgery center and Dr. Ong conducted the in-patient surgeries at a university medical center. They created a five-year prospective registry of all patients who received ambulatory hip or knee replacement surgeries starting in 2014. Results for 126 patients in the ambulatory group were matched to 126 patients in the in-patient group based on surgical procedure, age, sex, body mass index and health assessments. In each group, 77 patients underwent total hip replacements and 49 had total knee replacements.
The average length of stay in hospital was 8:09 hours for the ambulatory group, much shorter than 23:24 hours for the in-patient group. Overall, the rate of complications was low and there was no meaningful difference between groups: 3.9% for the in-patient group and 2.4% for the ambulatory group. There was also no significant difference between groups for readmission rates.
“I was very pleased to see there were no increased risks in complications or readmissions for ambulatory patients,” says Dr. Ast. “But I didn’t expect the cost difference would be so large — 40% less for the ambulatory group compared to the in-patient group.” Average costs per patient were $11,677 for the ambulatory group and $19,361 for the in-patient group. Costs included all costs associated with the surgery, such as the costs of the implant, staffing and medications, and immediate postoperative care.
Based on this pioneering work on an ambulatory surgical approach for hip and knee replacement surgery, Dr. Ast helped create the HSS outpatient joint program in partnership with other HSS surgeons. He explains that ambulatory surgery is best for patients who are relatively healthy, have support at home after surgery, and have few risk factors like heart disease, a history of blood clots, untreated sleep apnea, or require special medications after surgery.
By the year 2030, there will be an estimated 635,000 hip replacements and 1.28 million knee replacements every year. “If up to half of those are ambulatory procedures, at a savings of 40%, the healthcare system will save billions,” says Dr. Ast. “But patient outcomes are still our number one priority.”
About HSS | Hospital for Special Surgery HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In addition, HSS will be opening a new facility in Florida in late 2019. In 2018, HSS provided care to 139,000 patients and performed more than 32,000 surgical procedures, and people from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is the world’s leading provider of education on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.